HOME >> BIOLOGY >> NEWS
Doctors Find Lead On Common Genes Which Can Lead To Bowel Cancer

Doctors from the Imperial Cancer Research Fund, London, England have taken a step closer to identifying people who should be screened for bowel cancer. In new findings published this month (September 1998) in the Proceedings of the National Academy of Sciences* the research team confirm that two variants of the APC gene (a gene already associated with familial bowel cancer) do make people more susceptible to developing pre-cancerous polyps and thus predisposes them to bowel cancer.

Sir Walter Bodmer, head of the charity's Cancer and Immunogenetics Laboratory, Oxford explained: "We have found a new category of susceptibility to bowel cancer. What is interesting about these variants is that although they are hereditary their effect is not so strong as the other mutations which have already been identified with familial bowel cancer."

Dr Ian Frayling, Clincial Research Fellow with Imperial Cancer's Bowel Cancer Unit at St Mark's Hospital, added: "Not everyone who carries these variants of the APC gene will develop bowel cancer and so someone who carries the gene won't necessarily have a family history of the disease, but they might be at an increased risk of bowel cancer nonetheless."

Inherited mutations in the APC gene are responsible for a condition called Familial Adenomatous Polyposis (FAP) in which gene carriers get hundreds, often thousands, of polyps in their bowel and if the condition is not treated by surgery bowel cancer will develop. FAP is very rare (1 in 8000 individuals), but accounts for about one half a per cent of bowel cancer.

Added Dr Ian Tomlinson, head of Imperial Cancer's Molecular and Population Genetics Laboratory: "These new variants have a much more subtle effect and could be more common than the ones responsible for FAP. Someone who carries a standard APC gene mutation will have a risk of bowel cancer 40 times higher than normal. The risk for someone with one of these weaker variants may only be 5 times normal."
'"/>

Contact: Christine Suggars
suggars@icrf.icnet.uk
+44-171-269-3614
Imperial Cancer Research Fund
8-Sep-1998


Page: 1 2 3

Related biology news :

1. Doctors miss chances to help pregnant women quit smoking
2. Doctors miss chance to advise women of vitamin that prevents birth defects, survey finds
3. Doctors perform more IVF treatments, but multiple births decline
4. Doctors aware of Tylenol-related liver risk - but is the public getting the message?
5. Doctors failure to reevaluate asthma severity hurts wheezing sufferers
6. One In Three Doctors Recommends Herbal Supplements To Patients
7. Plant Doctors Find Genetic Solution For Papaya Growers
8. Phase Out Planned For One Of Top Five U.S. Pesticides, Plant Doctors Respond
9. New Heart-Attack Indicator Dramatically Improves Diagnostic Accuracy Of ER Doctors: TnT/Echocardiogram Combination Could Reduce Needless Admissions
10. Common cold virus can cause polio in mice when injected into muscles
11. Common call for action on European Research Council (ERC)

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Doctors Find Lead Common Genes Which Can Lead Bowel Cancer

(Date:12/17/2014)... 2014  Automation is fundamentally transforming the travel ... at international borders. Over the past decade, ePassports, ... veteran travelers to self process through border control ... at an increasing number of airports, seaports, and ... According to Maxine Most , Principal at ...
(Date:12/11/2014)... WINSTON SALEM, N.C. , Dec. 10, 2014  That ... known for quite a while. Hypertension – the medical term ... disease in the early 1800s, and the inflatable cuff that,s ... That doesn,t, however, mean there,s nothing new about hypertension, ... punctured some long-held beliefs about the condition and the best ...
(Date:12/10/2014)... N.C. , Dec. 9, 2014  Wake Forest Baptist ... education building for its School of Medicine. Funding for ... larger capital campaign that will be publicly launched next ... be located in the former 60 series R.J. Reynolds ... Innovation Quarter. Construction will begin immediately with plans to ...
Breaking Biology News(10 mins):Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4
(Date:12/17/2014)... (PRWEB) December 17, 2014 Gene ... that it has entered into a technology access ... (ADM) to apply DNA2.0’s proprietary protein engineering technology, ... process. , “We are extremely excited that the ... platform. This proprietary bioengineering technology has now ...
(Date:12/17/2014)... SOUTH SAN FRANCISCO, Calif. , Dec. 17, ... positive results of a Phase 2 study evaluating ... for the treatment of patients with severe, chronic ... the current standard of care, including topical steroids ... endpoint was percent change in Visual Analog Scale ...
(Date:12/15/2014)...  GlassesOff Inc. (OTCBB: GLSO) announced today the appointment ... director of the Company,s Board of Directors. ... its CEO until its acquisition by Stanley Black ... Recognized as the inventor of the first Wi-Fi-based Active ... -based RFID solutions focused on improving operational efficiency, safety ...
(Date:12/13/2014)... (PRWEB) December 12, 2014 Clarassance, a ... announced its new name: Therabron Therapeutics , Inc. ... and bronchioles (a type of structure in the lungs ... company’s mission to develop novel protein therapeutics for the ... directors decided to change the name to mark the ...
Breaking Biology Technology:ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4AeroScout Founder Joins GlassesOff's Board of Directors 2AeroScout Founder Joins GlassesOff's Board of Directors 3Maryland-based Biotech Company's Path Forward in Treating Respiratory Diseases Sparks Name Change 2
Cached News: